facebook page COVID-19 Information Center The post states that… international covid situation
China approves oral drug Paxlovid to treat coronavirus in adults
China’s National Medical Products Administration has approved Pfizer Inc.’s oral anti-COVID drug Paxlovid for the treatment of adults with mild to moderate symptoms of COVID-19. and high-risk patients It only increases the severity of symptoms, making Paxlovid the first anti-COVID drug to be approved for use in China. More studies of the drug will be conducted before full approval. Paxlovid has previously been approved in countries including Japan, South Korea, the United States and Israel.
Taiwan successfully tests self-researched mRNA vaccine found to produce 37 times more immunity than other vaccines
Taiwan says Academia Sinica has successfully tested its own research and developed COVID mRNA vaccine on mice. It was found that it can produce 37 times more immunity than other COVID vaccines currently in use.